Drugs / Ademetionine1,4-Butanedisulfonate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 1/2 | NCT01844063 Background | Jul 2013 → Jan 2016 | liver failure | Third Affiliated Hospital, Sun Yat-Sen University | Unknown | No outcome recorded |
| Phase 4 | NCT04553003 Comparator | Aug 2020 → Apr 2025 | drug-induced liver injury | Li Yang | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ademetionine1,4-Butanedisulfonate | “Ademetionine1,4-Butanedisulfonate” NCT04553003 ↗ |
| Known as | Ademetionine1,4-butanethiosulfonate | “B.Hepatoprotective drugs(Ademetionine1,4-butanethiosulfonate for Injection, Reduced Glutathione for Injection,Polyene Phosphatidylcholine, et al)” NCT01844063 ↗ |